Market Overview

NeoStem Prices 5M Share Offering at $7.00/Share


NeoStem (NASDAQ: NBS) today announced the pricing of an underwritten public offering of 5,000,000 shares of common stock at a public offering price of $7.00 per share. The Company expects to receive $35,000,000 in gross proceeds, before deducting underwriting discounts and commissions and offering expenses payable by the Company. The Company has granted the underwriters a 45-day option to purchase up to 750,000 additional shares of common stock. The Company intends to use the net proceeds from this offering for working capital, including research and development of cell therapeutic product candidates, including AMR-001, expansion of business units, strategic transactions and other general corporate purposes.

The financing is expected to close on or about October 9, 2013, subject to the satisfaction of customary closing conditions.

Aegis Capital Corp. acted as sole book-running manager of the offering.

This offering is being made pursuant to a shelf registration statement that the Company previously filed with the Securities and Exchange Commission (SEC) and which became effective on October 3, 2012. A preliminary prospectus supplement and accompanying prospectus relating to the offering were filed with the SEC, and a

See full press release

Posted-In: News Offerings


Related Articles (NBS)

View Comments and Join the Discussion!

Solera Holdings Signs JV Agreement with Welsh, Carson, Anderson & Stowe

Cherry Hill Mortgage Prices 6.5M Share IPO at $20.00/Share